MEDXF News and Press, Medexus Pharmaceuticals Inc From 11/15/21

Small and Micro-cap investors are invited to attend the Q4 Investor Summit being held on November 16-17, 2021. The event is organized by the Investor Summit Group, recognised as a highly reputed brand for hosting North America’s largest independent investor conferences. Over 90 pre...

Medexus Pharmaceuticals, Inc. (MEDXF) Q2 2022 Earnings Conference Call November 11, 2021 8:00 AM ET Company Participants Tina Byers - IR Ken d’Entremont - CEO Marcel Konrad - CFO Conference Call Participants Justin Keywood - Stifel GMP Andre Uddin - Research Capital Prasath Pandurangan...

Medexus Pharmaceuticals (OTCQX:MEDXF): Q3 Non-GAAP net income of $6.1M; Net income of $10.1M. Revenue of $17.9M (+0.6% Y/Y) Press Release For further details see: Medexus Pharmaceuticals reports Q3 results

Medexus Pharmaceuticals (OTCQX:MEDXF): Q2 Net Income of $10.1M; Adjusted Net Loss of $6.1M Revenue of $17.9M (+0.6% Y/Y) misses by $0.15M. Cash and cash equivalents of $8.1M. Press Release For further details see: Medexus Pharmaceuticals misses on revenue

Achieved $17.9 million revenue driven by continued strength of Rupall ™ Positioned for revenue growth along with expected recovery of IXINITY ® sales Commercially launched Trecondyv ® (treosulfan) in Canada Available liqui...

TORONTO and CHICAGO, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or “Medexus ”) (TSX: MDP) (OTCQX: MEDXF) today announced that management will present at the Q4 Investor Summit, hosted by the Investor Summit Group, bein...

TORONTO and CHICAGO, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or “Medexus ”) (TSX: MDP) (OTCQX: MEDXF) today announced that it plans to host a conference call at 8:00 AM Eastern Time on Thursday, November 11, 2021 to...

TORONTO and CHICAGO, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“ Medexus ” or the “ Company ”) (TSX: MDP) (OTCQX: MEDXF) and medac GmbH (“ medac ”) today announced that the U.S. Food and Drug Administration (“...

TORONTO and CHICAGO and MONTREAL, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or “Medexus ”) (TSX: MDP) (OTCQX: MEDXF) today announced that Ken d’Entremont, Chief Executive Officer of Medexus, and Marcel Konrad, ...

TORONTO and CHICAGO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or “Medexus ”) (TSX: MDP) (OTCQX: MEDXF) announced today that it has initiated its first commercial shipment of Trecondyv® (treosulfan) in Canada, f...